Suppression of Diacylglycerol Levels by Antibodies Reactive with the c-erbB-2 (HER-2/neu) Gene Product p185 c-erbB-2 in Breast and Ovarian Cancer Cell Lines

Author： Boente M.P.   Berchuck A.   Whitaker R.S.   Kalen A.   Xu F.-J.   Clarke-Pearson D.L.   Bell R.M.   Bast R.C.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.70, Iss.1, 1998-07, pp. : 49-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

C-erbB-2 overexpression and survival in early onset breast cancer

By Agrup M.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 1, 2000-09 ,pp. : 23-29

Springer Publishing Company

Access to resources Recommend Favorite

Correlativity study on mammographic features and c-erbB-2 of breast cancer

By Ma Jie   Zuo Min   Sun Guoping   Zang Da   Wang Xiaomei   Xu Jianmin  

The Chinese-German Journal of Clinical Oncology, Vol. 5, Iss. 5, 2006-10 ,pp. : 350-353

Springer Publishing Company

Access to resources Recommend Favorite

Combination Antigene Therapy Targeting c-myc and c-erbB 2 in the Ovarian Cancer COC 1 Cell Line

By Fei R.   Shaoyang L.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 40-44

Elsevier

Access to resources Recommend Favorite

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

By Youngren Jack  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 37-46

Springer Publishing Company

Access to resources Recommend Favorite

The expressions and clinical significance of P53, C-erbB-2 and VEGF in non-small cell lung cancer

By Gu Aiqin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 78-80

Springer Publishing Company

Access to resources Recommend Favorite